AstraZeneca expects EUA in US for COVID-19 vaccine in April
The company expects to be able to deliver 50 million doses of the vaccine by the end of April
AstraZeneca expects its COVID-19 vaccine could receive US Emergency Use Authorisation (EUA) at the beginning of April and could immediately deliver 30 million doses of the shot there, a top executive said at a hearing in the US House of Representatives.
Ruud Dobber, Executive VP at AstraZeneca, said that the drugmaker expects to be able to deliver 50 million doses of the vaccine by the end of April.
(Edits by EP News Bureau)